Diagnostyka

Diagnostyka EBIT Margin

The EBIT Margin (Operating Margin) of Diagnostyka (DIA.WA) as of Oct 27, 2026 is 15.92 %. In the previous year, EBIT Margin (Operating Margin) was 17.29 % — a change of -7.97% (lower).

EBIT Margin

15.92 %

YoY

-7.97%

Last updated:

EBIT Margin (Operating Margin) of Diagnostyka is 2025 15.92 % . EBIT Margin (Operating Margin) of Diagnostyka was 2024 17.29 % . It decreases by -7.97% lower compared to the previous year.

For Diagnostyka, the operating (EBIT) margin of 16.4% is down versus 37.8% a few years ago.

The Diagnostyka EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2021
37.31 PLN
Jan 1, 2022
17.56 PLN
Jan 1, 2023
14.70 PLN
Jan 1, 2024
17.29 PLN
Jan 1, 2025
15.92 PLN
The Diagnostyka EBIT Margin history
YEAREBIT MarginYoY
15.92 %-7.97%
17.29 %+17.65%
14.70 %-16.27%
17.56 %-52.94%
37.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

EBIT Margin (Operating Margin) of Diagnostyka is 15.92 % in 2025.

EBIT Margin (Operating Margin) of Diagnostyka changed from 17.29 % to 15.92 %, representing a -7.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Diagnostyka with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Diagnostyka

All Key Metrics — Diagnostyka